ArticleBreast cancer research : BCR2022

Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 years.

Gerardo Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.